These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25213349)

  • 41. Whole saliva and plasma levels of clozapine and desmethylclozapine.
    Dumortier G; Lochu A; Zerrouk A; Van Nieuwenhuyse V; Colen de Melo P; Roche Rabreau D; Degrassat K
    J Clin Pharm Ther; 1998 Feb; 23(1):35-40. PubMed ID: 9756110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sleep EEG and spindle characteristics after combination treatment with clozapine in drug-resistant schizophrenia: a pilot study.
    Tsekou H; Angelopoulos E; Paparrigopoulos T; Golemati S; Soldatos CR; Papadimitriou GN; Ktonas PY
    J Clin Neurophysiol; 2015 Apr; 32(2):159-63. PubMed ID: 25350635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.
    Havaki-Kontaxaki BJ; Ferentinos PP; Kontaxakis VP; Paplos KG; Soldatos CR
    Clin Neuropharmacol; 2006; 29(1):52-6. PubMed ID: 16518135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clozapine-induced EEG abnormalities and clinical response to clozapine.
    Risby ED; Epstein CM; Jewart RD; Nguyen BV; Morgan WN; Risch SC; Thrivikraman KV; Lewine RL
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):466-70. PubMed ID: 8555749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.
    Kinoshita M; Numata S; Tajima A; Yamamori H; Yasuda Y; Fujimoto M; Watanabe S; Umehara H; Shimodera S; Nakazawa T; Kikuchi M; Nakaya A; Hashimoto H; Imoto I; Hashimoto R; Ohmori T
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risperidone augmentation of clozapine: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment.
    Jin Y; Potkin SG; Sandman CA; Bunney WE
    Clin Electroencephalogr; 1998 Apr; 29(2):73-8. PubMed ID: 9571294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood Pressure and Heart Rate Changes During Clozapine Treatment.
    Norman SM; Sullivan KM; Liu F; DiPaula BA; Jose PA; Kitchen CA; Feldman SM; Kelly DL
    Psychiatr Q; 2017 Sep; 88(3):545-552. PubMed ID: 27678498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model.
    Dal Santo F; Jarratt-Barnham I; González-Blanco L; García-Portilla MP; Bobes J; Fernández-Egea E
    Eur Neuropsychopharmacol; 2020 Apr; 33():158-163. PubMed ID: 32057590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropharmacological computational analysis of longitudinal electroencephalograms in clozapine-treated patients with schizophrenia using hierarchical dynamic causal modeling.
    Eo J; Kang J; Youn T; Park HJ
    Neuroimage; 2023 Jul; 275():120161. PubMed ID: 37172662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics.
    Knott VJ; LaBelle A; Jones B; Mahoney C
    Exp Clin Psychopharmacol; 2002 Nov; 10(4):435-44. PubMed ID: 12498341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Machine-learning-based diagnosis of schizophrenia using combined sensor-level and source-level EEG features.
    Shim M; Hwang HJ; Kim DW; Lee SH; Im CH
    Schizophr Res; 2016 Oct; 176(2-3):314-319. PubMed ID: 27427557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Factors Associated with New-Onset Glucose Intolerance among Patients with Schizophrenia during Clozapine Treatment: All-Case Surveillance in Japan.
    Ishibashi M; Matsui K; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
    Tohoku J Exp Med; 2020 Oct; 252(2):177-183. PubMed ID: 33055431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clozapine blockade of MK-801-induced learning/memory impairment in the mEPM: Role of 5-HT
    López Hill X; Richeri A; Scorza MC
    Physiol Behav; 2017 Oct; 179():346-352. PubMed ID: 28705535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia.
    Kikuchi YS; Kanbayashi T; Shimizu T
    Psychiatry Investig; 2018 Apr; 16(4):279-284. PubMed ID: 30947495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.
    Lin BD; Pinzón-Espinosa J; Blouzard E; van der Horst MZ; Okhuijsen-Pfeifer C; van Eijk KR; Guloksuz S; Peyrot WJ; Luykx JJ;
    JAMA Psychiatry; 2023 Feb; 80(2):181-185. PubMed ID: 36542388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.
    Simosky JK; Stevens KE; Adler LE; Freedman R
    Psychopharmacology (Berl); 2003 Feb; 165(4):386-96. PubMed ID: 12459928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between plasma clozapine/N-desmethylclozapine and changes in basal forebrain-dorsolateral prefrontal cortex coupling in treatment-resistant schizophrenia.
    Sarpal DK; Blazer A; Wilson JD; Calabro FJ; Foran W; Kahn CE; Luna B; Chengappa KNR
    Schizophr Res; 2022 May; 243():170-177. PubMed ID: 35381515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.